Pfizer
- Business
Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings
Swiss health care company Roche on Monday announced it would acquire Telavant Holdings in a $7.1 billion transaction. Telavant is…
Read More » - Business
Drug companies face COVID cliff in 2023 as sales set to plummet
Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up…
Read More » - Business
Pfizer quarterly sales surge to record high, driven by Covid vaccine and antiviral treatment Paxlovid
Pfizer’s revenue grew by 47% to $27.7 billion compared to the second quarter last year.The pharmaceutical company booked net income…
Read More » - Business
Stocks making the biggest moves premarket: Spirit Airlines, BioNTech, Robinhood and more
Spirit Airlines lost 4.7% in the premarket after saying it would accept the latest improved takeover bid from Frontier Group…
Read More » - Business
Pfizer to acquire Biohaven Pharmaceuticals in $11.6B cash deal
Biohaven known for developing migraine treatment, prevention of it in adults US-based multinational biotechnology firm Pfizer announced Tuesday it will…
Read More » - Business
BioNTech profits jump to $11.5B in 2021, up from $17M in 2020
Germany-based coronavirus vaccine developer and producer BioNTech reported a whopping 10.3 billion euros ($11.5 billion) in profits in 2021, skyrocketing…
Read More » - Business
BioNTech unveils plans for container vaccine factories in Africa
Facilities will be able to make various mRNA-based vaccines, including Pfizer-BioNTech COVID-19 jab, says German firm German pharma firm BioNTech…
Read More » - Business
FDA set to authorize Pfizer, Merck COVID-19 pills this week
The United States Food and Drug Administration (FDA) is set to authorize COVID-19 treatment pills from both Pfizer Inc. and…
Read More » - Business
COVID-19 expected to become endemic as early as 2024: Pfizer
Over next year, some regions will transition to endemic, while others will continue in pandemic, one executive says COVID-19 is…
Read More » - Business
Pfizer to buy Arena Pharmaceuticals for $6.7B
Arena’s stock price jumps 48% on Nasdaq US biotechnology firm Pfizer announced Monday it will buy California-based pharmaceutical company Arena…
Read More »